<?xml version='1.0' encoding='utf-8'?>
<document id="29425645"><sentence text="Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats." /><sentence text="Sailuotong (SLT) is a standard Chinese preparation made from extracts of Panax ginseng (ginseng), Ginkgo biloba (ginkgo), and Crocus sativus (saffron)" /><sentence text=" Preliminary clinical trials and animal experiments have demonstrated that SLT could improve cognition of vascular dementia (VD)" /><sentence text="" /><sentence text="To avoid incident drug-drug interaction which is easily encountered in patients of VD, the potential influence of SLT on main drug-metabolic cytochromes P450 enzymes (CYP450) was investigated" /><sentence text="" /><sentence text="A &quot;cocktail probes&quot; approach was employed to evaluate the activities of CYP450" /><sentence text=" A rapid and selective analysis method was developed to examine 5 CYP probe drugs and their specific metabolites in plasma by using online SPE followed by a single LC-MS/MS run" /><sentence text=" After pretreatment for 2 weeks with SLT, ginseng, gingko, saffron or water (control), a cocktail solution containing caffeine, losartan, omeprazole, dextromethorphan and midazolam was given to rats orally"><entity charOffset="118-126" id="DDI-PubMed.29425645.s9.e0" text="caffeine" /><entity charOffset="128-136" id="DDI-PubMed.29425645.s9.e1" text="losartan" /><entity charOffset="138-148" id="DDI-PubMed.29425645.s9.e2" text="omeprazole" /><entity charOffset="150-166" id="DDI-PubMed.29425645.s9.e3" text="dextromethorphan" /><entity charOffset="171-180" id="DDI-PubMed.29425645.s9.e4" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e0" e2="DDI-PubMed.29425645.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e0" e2="DDI-PubMed.29425645.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e0" e2="DDI-PubMed.29425645.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e0" e2="DDI-PubMed.29425645.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e0" e2="DDI-PubMed.29425645.s9.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e1" e2="DDI-PubMed.29425645.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e1" e2="DDI-PubMed.29425645.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e1" e2="DDI-PubMed.29425645.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e1" e2="DDI-PubMed.29425645.s9.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e2" e2="DDI-PubMed.29425645.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e2" e2="DDI-PubMed.29425645.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e2" e2="DDI-PubMed.29425645.s9.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e3" e2="DDI-PubMed.29425645.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s9.e3" e2="DDI-PubMed.29425645.s9.e4" /></sentence><sentence text=" The plasma was obtained at different time intervals and then measured for the concentration of probes and their metabolites using developed SPE-LC-MS/MS method" /><sentence text=" Activity of five isozymes was estimated by comparing plasma pharmacokinetics of substrates and their metabolites (caffeine/paraxanthine for CYP1A2, losartan/E-3174 for CYP2C11, omeprazole/5-hydroxyl omeprazole for CYP2C6, dextromethorphan/dextrophan for CYP2D2 and midazolam/1-hydroxyl midazolam for CYP3A1/2) between control and drug treatment groups"><entity charOffset="115-123" id="DDI-PubMed.29425645.s11.e0" text="caffeine" /><entity charOffset="124-136" id="DDI-PubMed.29425645.s11.e1" text="paraxanthine" /><entity charOffset="149-157" id="DDI-PubMed.29425645.s11.e2" text="losartan" /><entity charOffset="158-164" id="DDI-PubMed.29425645.s11.e3" text="E-3174" /><entity charOffset="169-176" id="DDI-PubMed.29425645.s11.e4" text="CYP2C11" /><entity charOffset="178-188" id="DDI-PubMed.29425645.s11.e5" text="omeprazole" /><entity charOffset="189-210" id="DDI-PubMed.29425645.s11.e6" text="5-hydroxyl omeprazole" /><entity charOffset="215-221" id="DDI-PubMed.29425645.s11.e7" text="CYP2C6" /><entity charOffset="223-239" id="DDI-PubMed.29425645.s11.e8" text="dextromethorphan" /><entity charOffset="240-250" id="DDI-PubMed.29425645.s11.e9" text="dextrophan" /><entity charOffset="255-261" id="DDI-PubMed.29425645.s11.e10" text="CYP2D2" /><entity charOffset="266-275" id="DDI-PubMed.29425645.s11.e11" text="midazolam" /><entity charOffset="276-296" id="DDI-PubMed.29425645.s11.e12" text="1-hydroxyl midazolam" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e0" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e1" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e5" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e0" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e1" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e5" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e1" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e5" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e2" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e3" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e5" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e3" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e4" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e5" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e4" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e5" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e5" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e6" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e6" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e7" e2="DDI-PubMed.29425645.s11.e7" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e7" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e7" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e7" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e7" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e7" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e8" e2="DDI-PubMed.29425645.s11.e8" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e8" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e8" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e8" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e8" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e9" e2="DDI-PubMed.29425645.s11.e9" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e9" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e9" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e9" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e10" e2="DDI-PubMed.29425645.s11.e10" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e10" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e10" e2="DDI-PubMed.29425645.s11.e12" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e11" e2="DDI-PubMed.29425645.s11.e11" /><pair ddi="false" e1="DDI-PubMed.29425645.s11.e11" e2="DDI-PubMed.29425645.s11.e12" /></sentence><sentence text="" /><sentence text="Compared with control group, repeated administration of SLT induced CYP1A2 by enhancing AUC paraxanthine / AUC caffeine to144%"><entity charOffset="92-104" id="DDI-PubMed.29425645.s13.e0" text="paraxanthine" /><entity charOffset="111-119" id="DDI-PubMed.29425645.s13.e1" text="caffeine" /><pair ddi="false" e1="DDI-PubMed.29425645.s13.e0" e2="DDI-PubMed.29425645.s13.e0" /><pair ddi="false" e1="DDI-PubMed.29425645.s13.e0" e2="DDI-PubMed.29425645.s13.e1" /></sentence><sentence text=" The influence is attributed to its herbal component of ginseng to a large extent" /><sentence text=" Meanwhile, metabolic ability towards losartan was significantly elevated in SLT and gingko group by 31% and 25% respectively, indicating weak induction of CYP2C11 in rats"><entity charOffset="38-46" id="DDI-PubMed.29425645.s15.e0" text="losartan" /></sentence><sentence text=" The analysis on probes of omeprazole and dextromethorphan showed a lack of influence on CYP 2C6 and CYP2D2 in all treated groups"><entity charOffset="27-37" id="DDI-PubMed.29425645.s16.e0" text="omeprazole" /><entity charOffset="42-58" id="DDI-PubMed.29425645.s16.e1" text="dextromethorphan" /><pair ddi="false" e1="DDI-PubMed.29425645.s16.e0" e2="DDI-PubMed.29425645.s16.e0" /><pair ddi="false" e1="DDI-PubMed.29425645.s16.e0" e2="DDI-PubMed.29425645.s16.e1" /></sentence><sentence text=" In terms of CYP3A1/2, SLT decreased AUC ratio of 1-hydroxyl midazolam to midazolam by 39% and extended the half-life of midazolam apparently"><entity charOffset="50-70" id="DDI-PubMed.29425645.s17.e0" text="1-hydroxyl midazolam" /><entity charOffset="74-83" id="DDI-PubMed.29425645.s17.e1" text="midazolam" /><entity charOffset="121-130" id="DDI-PubMed.29425645.s17.e2" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.29425645.s17.e0" e2="DDI-PubMed.29425645.s17.e0" /><pair ddi="false" e1="DDI-PubMed.29425645.s17.e0" e2="DDI-PubMed.29425645.s17.e1" /><pair ddi="false" e1="DDI-PubMed.29425645.s17.e0" e2="DDI-PubMed.29425645.s17.e2" /><pair ddi="false" e1="DDI-PubMed.29425645.s17.e1" e2="DDI-PubMed.29425645.s17.e1" /><pair ddi="false" e1="DDI-PubMed.29425645.s17.e1" e2="DDI-PubMed.29425645.s17.e2" /></sentence><sentence text=" Besides, significantly decreased systematic exposure of midazolam suggested the inhibition on metabolism of CYP3A1/2 is likely secondary to the interaction on absorption at intestinal level"><entity charOffset="57-66" id="DDI-PubMed.29425645.s18.e0" text="midazolam" /></sentence><sentence text=" The inhibition of SLT on CYP3A was likely attributed to ginseng and gingko cooperatively" /><sentence text="" /><sentence text="Further observation on herb-drug interaction should be considered during clinical application of SLT" /><sentence text="" /></document>